Atara Biotherapeutics (ATRA) Asset Utilization Ratio (2021 - 2026)
Atara Biotherapeutics' (ATRA) quarterly Asset Utilization Ratio came in at 1.15 in Q1 2026, down 50.72% YoY from 2.33 in Q1 2025, and down 76.0% on a QoQ basis from 4.79 in Q4 2025.
Atara Biotherapeutics (ATRA) Asset Utilization Ratio (2021 - 2026) Analysis & Trends
Atara Biotherapeutics (ATRA) has 6 years of Asset Utilization Ratio data on file, last reported at 1.15 in Q1 2026.
- Quarterly Asset Utilization Ratio fell 50.72% year-over-year to 1.15 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.15 (down 50.72% YoY) and the FY2025 annual result came in at 1.87, up 98.87% from the prior year.
- Asset Utilization Ratio fell to 1.15 in Q1 2026, from 4.79 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 4.79 in Q4 2025 to a low of 0.0 in Q4 2023.
- A 5-year average of 1.16 and a median of 0.17 in 2023 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2023 — Asset Utilization Ratio sank 99.79% — and 2024, when it surged 312693.99%.
- Tracing ATRA's Asset Utilization Ratio over 5 years: stood at 0.16 in 2022, then plunged by 99.79% to 0.0 in 2023, then soared by 312693.99% to 1.02 in 2024, then surged by 367.94% to 4.79 in 2025, then tumbled by 76.0% to 1.15 in 2026.
- The last three Asset Utilization Ratio figures came in at 1.15 (Q1 2026), 4.79 (Q4 2025), and 4.53 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 0.90 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.54 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.13 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.13 |
| 10 | Atara Biotherapeutics | 140.71 Mn | 124.16 Mn | 439,000.00 | 0.30 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.30 |
| Mar 31, 2026 | 1.15 |
| Dec 31, 2025 | 4.79 |
| Sep 30, 2025 | 4.53 |
| Jun 30, 2025 | 3.81 |
| Mar 31, 2025 | 2.33 |
| Dec 31, 2024 | 1.02 |
| Sep 30, 2024 | 0.72 |
| Jun 30, 2024 | 0.39 |
| Mar 31, 2024 | 0.16 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.02 |
| Jun 30, 2023 | 0.03 |
| Mar 31, 2023 | 0.17 |
| Dec 31, 2022 | 0.16 |
| Sep 30, 2022 | 0.16 |
| Jun 30, 2022 | 0.15 |
| Mar 31, 2022 | 0.04 |
| Dec 31, 2021 | 0.04 |
| Sep 30, 2021 | 0.03 |